Pharma Pulse 7/2/24: Employers to Maintain Benefits Despite Rising Costs, Amazon Invests in Its AI Future & more

Future Use of Artificial Intelligence in Clinical Trials

In the fifth and final part of this video interview, Diane Lacroix, vice president, clinical data management, eClinical Solutions looks to the future and touches on what the use of AI in clinical trials could like in five years.

Most Employers Plan to Maintain Benefits Despite Rising Costs

Healthcare costs are on the rise, but most employers don’t plan to cut their benefits, according to the results of a recent survey by Mercer, a global consulting firm. The results of their Survey on Health and Benefit Strategies for 2025 were published yesterday.

Amazon, Built by Retail, Invests in Its AI Future

The freshly minted $2 trillion company is now investing more on data-center infrastructure than on retail warehouses.

Radionetics Oncology Enters Into Strategic Agreement With Lilly
Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein coupled receptor (GPCR) targeted radiopharmaceuticals to treat a broad range of solid tumors, announced today the formation of a strategic relationship with Eli Lilly and Company to take forward Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals.

Chiraag Bhadana, MBA on LinkedIn

Joe DeLuca and I collaborated on this piece to explore how AI is transforming (and also delivering) on how we connect with patients from a marketing perspective today and the challenges ahead:

✅ Precision targeting: AI is helping identify the right patients at the right time, potentially increasing the impact of treatments.
✅Personalized on-boarding: AI-powered tools can guide patients through treatment plans, boosting adherence and understanding.
✅Data-driven insights via online listening: We can now analyze online feedback in real-time, allowing us to better understand and respond to patient needs.

But it's not all smooth sailing. How do we balance innovation with privacy concerns? And how can we ensure AI is used ethically and responsibly in patient marketing programs when it comes to health?
#AI #Pharma #PatientMarketing #GDPR #HIPAA #Adherence

Thank you to Pharmaceutical Executive & Miranda Schmalfuhs for the opportunity!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs